Its digital-first model appeals to patients who prefer managing healthcare from home
"The findings provide important comparative effectiveness information until randomized head-to-head studies become available." Reference: Ildiko Lingvay, Robert Bauer, James Baker-Knight, Jack Lawson, Richard Pratley, An indirect treatment comparison of semaglutide 2.0 mg versus dulaglutide 3.0 mg and 4.5 mg using multilevel network meta-regression, The Journal of Clinical Endocrinology & Metabolism, 2021;, dgab905, MSc
Schultz HS, stergaard S, Sidney J, Lamberth K, Sette A
At roughly $550/month for the lower doses, it undercuts what many patients have been paying for third-party compounders once shipping and consultation fees are factored in